TITLE

Nonalcoholic fatty liver disease

AUTHOR(S)
Adams, Leon A.; Angulo, Paul; Lindor, Keith D.
PUB. DATE
March 2005
SOURCE
CMAJ: Canadian Medical Association Journal;3/29/2005, Vol. 172 Issue 7, p899
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.
ACCESSION #
16456739

 

Related Articles

  • A BIRD'S EYE VIEW OF NON ALCOHOLIC FATTY LIVER DISEASE- AND INSULIN RESISTANT STATE.  // Acta Medica Saliniana;2010, Vol. 39 Issue 1, p1 

    No abstract available.

  • Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Petit, Jean; Hamza, Samia; Rollot, Fabien; Sigonney, Vanessa; Crevisy, Elodie; Duvillard, Laurence; Raab, Jean; Bronowicki, Jean; Bernard-Chabert, Brigitte; Martino, Vincent; Doffoel, Michel; Barraud, Helene; Richou, Carine; Jouve, Jean; Hillon, Patrick // Acta Diabetologica;Jun2014, Vol. 51 Issue 3, p455 

    The association between liver cirrhosis (LC) and diabetes mellitus (DM) is well known. However, the impact of the severity or etiology of LC on the occurrence of DM is relatively unknown. We aimed to determine the prevalence and clinical correlates of DM in a large cohort of patients with...

  • Liver failure after hepatocellular carcinoma surgery. Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Furusawa, Norihiko; Sakai, Hiroshi; Kitagawa, Noriyuki; Ohkubo, Yohei; Tsukahara, Teruomi; Miyagawa, Shin-ichi // Langenbeck's Archives of Surgery;Dec2014, Vol. 399 Issue 8, p1047 

    Purpose: The aim of this study was to construct a prediction model for posthepatectomy liver failure (PHLF), as defined by the International Study Group of Liver Surgery, and evaluate its accuracy in hepatocellular carcinoma (HCC) patients with cirrhosis or chronic hepatitis. Methods: A total of...

  • Survey of 2002 cases of liver cirrhosis : Identification of etiological factors and related complications. AL, Min; CHEN, Weichan; SHEN, Wei // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;May2013, Vol. 29 Issue 5, p352 

    To identify the etiologies and associated complications of liver cirrhosis for new cases emerging over the past decade in the region served by the Second Affiliated Clinical College of Chongqing University of Medical Sciences. Methods The institute's inpa-tient medical record database was...

  • Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis. Segers, Filip M.; Verdam, Froukje J.; de Jonge, Charlotte; Boonen, Bas; Driessen, Ann; Shiri-Sverdlov, Ronit; Bouvy, Nicole D.; Greve, Jan Willem M.; Buurman, Wim A.; Rensen, Sander S. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    The innate immune system plays a major role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Recently we reported complement activation in human NASH. However, it remained unclear whether the alternative pathway of complement, which amplifies C3 activation and which is frequently...

  • Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Catalano, Daniela; Martines, Giuseppe; Tonzuso, Antonia; Pirri, Clara; Trovato, Francesca; Trovato, Guglielmo; Martines, Giuseppe Fabio; Trovato, Francesca M; Trovato, Guglielmo M // Digestive Diseases & Sciences;Nov2010, Vol. 55 Issue 11, p3200 

    Aim: The benefits of coffee on abnormal liver biochemistry, cirrhosis and hepatocellular carcinoma have been reported, but there is a lack of satisfactory explanation. Thus, this study aims to investigate if coffee use has any relationship with bright liver, measured by ultrasound...

  • love your liver. Kane, Emily A. // Better Nutrition;Oct2009, Vol. 71 Issue 10, p24 

    The article offers information on the nonalcoholic fatty liver disease (NAFLD) that is stated to be the most common liver disease in the U.S. It reportedly has two stages viz the hepatic steatosis due to insulin resistance and non alcoholic steatotic hepatitis. The liver inflammation leads to...

  • Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. Kawanaka, Miwa; Nishino, Ken; Nakamura, Jun; Suehiro, Mitsuhiko; Goto, Daisuke; Urata, Noriyo; Oka, Takahito; Kawamoto, Hirofumi; Nakamura, Hajime; Yodoi, Junji; Hino, Keisuke; Yamada, Gotaro // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p11 

    Background: Nonalcoholic steatohepatitis (NASH) is a common liver disease that can progress to cirrhosis. Oxidative stress is one of the central mechanisms causing hepatocellular injury in the disease. In this study, antioxidant therapy using both vitamins C and E was conducted in patients with...

  • Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies. Nseir, William; Mograbi, Julnar; Ghali, Murad // Digestive Diseases & Sciences;Jul2012, Vol. 57 Issue 7, p1773 

    Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which refers to the presence of hepatic steatosis without significant intake of alcohol. NAFLD is an asymptomatic disease that can progress to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics